DNLI Stock-Based Compensation
Denali Therapeutics Inc · Stock-Based Compensation
DNLI Stock-Based Compensation
Latest reported$22.92Mperiod ending
DNLI Quarterly Stock-Based Comp ($550.00K → $22.92M)
Quarterly stock-based compensation
High-resolution chart · PNG
DNLI stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 22,915,000 | |
| 23,087,000 | |
| 23,951,000 | |
| 0 | |
| 0 | |
| 25,160,000 | |
| 25,078,000 | |
| 0 | |
| 25,100,000 | |
| 27,840,000 | |
| 25,988,000 | |
| 27,460,000 | |
| 0 | |
| 28,084,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 13,252,000 | |
| 0 | |
| 10,785,000 | |
| 0 | |
| 8,901,000 | |
| 13,714,000 | |
| 6,874,000 | |
| 5,646,000 | |
| 5,510,000 | |
| 4,710,000 | |
| 2,925,000 | |
| 1,457,000 | |
| 1,128,000 | |
| 1,059,000 | |
| 765,000 | |
| 691,000 | |
| 1,160,000 | |
| 550,000 | |
| 550,000 |